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Vertebrate Wnt proteins activate several distinct
pathways. Intrinsic differences among Wnt ligands
and Frizzled (Fzd) receptors, and the availability of
pathway-specific coreceptors, LRP5/6, and Ror2,
affect pathway selection. Here, we show that a se-
creted glycoprotein, Cthrc1, is involved in selective
activation of the planar cell polarity (PCP) pathway
by Wnt proteins. Although Cthrc1 null mutant mice
appeared normal, the introduction of a heterozygous
mutation of a PCP gene, Vangl2, resulted in abnor-
malities characteristic of PCP mutants. In HEK293T
cells, Cthrc1 activated the PCP pathway but sup-
pressed the canonical pathway. Cell-surface-an-
chored Cthrc1 bound to Wnt proteins, Fzd proteins,
and Ror2 and enhanced the interaction of Wnt pro-
teins and Fzd/Ror2 by forming the Cthrc1-Wnt-Fzd/
Ror2 complex. Consistent with this, Ror2 mutant
mice also showed PCP-related abnormalities in the
inner ear. These results suggest that Cthrc1 is
a Wnt cofactor protein that selectively activates the
Wnt/PCP pathway by stabilizing ligand-receptor
interaction.
INTRODUCTION
Wnt proteins are members of a family of secreted signaling mol-
ecules that have multiple roles in the development of the organ-
ism throughout the animal kingdom. In vertebrates, Wnt proteins
play central roles in regulation of body-axis specification, pat-
terning of germ layers and tissues, differentiation and prolifera-
tion of stem/progenitor cells, morphogenetic movements during
embryogenesis and organogenesis, and growth and metastasis
of cancers/tumors. At the cellular level, such multifunctionality of
Wnt signaling is achieved through the activation of different intra-
cellular signaling pathways (Logan and Nusse, 2004; Veeman
et al., 2003a).The best-characterized pathway is the canonical Wnt path-
way, which leads to the stabilization of b-catenin proteins (Logan
and Nusse, 2004). An increase in the b-catenin level leads to its
translocation to the nucleus, where it interacts with TCF/LEF-
family transcription factors to activate the expression of target
genes. During vertebrate development, canonical Wnt signaling
is involved in determining cell fate and the regulation of growth,
including formation of the body axis, patterning of the neuroec-
toderm, and amplification of neural progenitors. The noncanon-
ical pathway is further classified into two subsidiary pathways:
Wnt/planar cell polarity (PCP) and Wnt/Ca2+ (Habas and Dawid,
2005). The downstream components of the Wnt/PCP pathway
resemble those of PCP signaling in Drosophila. The Wnt/PCP
pathway promotes activation of small GTPases, including
RhoA and Rac1, and their downstream protein kinases, ROCK
and JNK, respectively, to regulate actin polymerization. In verte-
brates, Wnt/PCP signaling plays important roles in morphoge-
netic processes, including convergent-extension movements
during gastrulation and the alignment of the ciliary bundle of
the sensory hair cells of the organ of Corti. In contrast,
the Wnt/Ca2+ pathway is characterized to a lesser extent. It
promotes the intracellular increase in Ca2+ concentration and
activates Ca2+-sensitive enzymes such as PKC, CamKII, and
calcineurin.
A detailed mechanism of the selective activation of certain sig-
naling pathways by Wnt proteins is not known. Vertebrate Wnt
proteins have been classified into two groups (Shimizu et al.,
1997; Slusarski et al., 1997). One group, including Wnt1,
Wnt3a, and Wnt8, contain Wnt proteins often referred to as ‘‘ca-
nonical Wnt proteins’’; they stimulate the canonical Wnt path-
way, whereas Wnt5a and Wnt11 are classified as ‘‘noncanonical
Wnt proteins.’’ Such differential activities indicate that pathway
selection depends on the intrinsic nature of Wnt proteins. In con-
trast to these observations, the relationships between Wnt pro-
teins and pathways are not strictly maintained in cultured cells
(Kishida et al., 2004; Mikels and Nusse, 2006), indicating that
pathway selection by Wnt proteins depends on the cellular con-
text.Wnt proteins use Frizzled (Fzd) receptors and pathway-spe-
cific coreceptors for signaling. LRP5 and LRP6 are coreceptors
for the canonical pathway (Pinson et al., 2000; Tamai et al.,
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way (Hikasa et al., 2002; Oishi et al., 2003). The availability of
these coreceptors also affects pathway selection by Wnt pro-
teins (Mikels and Nusse, 2006).
In the present work, we found that the protein collagen triple
helix repeat containing 1 (Cthrc1) is involved in the selective ac-
tivation of the PCP pathway by Wnt proteins. Cthrc1 was origi-
nally identified as an overexpressed gene in injured rat arteries,
and it encodes a secreted glycoprotein with 12 repeats of the
GXY motif, which is characteristic of collagens (Pyagay et al.,
2005). Cthrc1 increases cellularmotility to repair the injury by lim-
iting the deposition of collagen matrix and promoting cell migra-
tion (Pyagay et al., 2005). Aberrant expression of Cthrc1 is also
observed in some metastatic melanoma cells (Tang et al.,
2006). Therefore, Cthrc1 is considered to be a promigratory
protein.
Here, we examined the role of theCthrc1 gene during develop-
ment in the mouse. Cthrc1 null mutants did not exhibit obvious
abnormalities, but introduction of a heterozygous mutation of
a PCP gene, vang-like 2 (Vangl2), into this mutant background
(Cthrc1LacZ/LacZ;Vangl2Lp/+) resulted in clear PCP phenotypes.
In HEK293T cells, Cthrc1 activated the PCP pathway by promot-
ing the formation of a ligand-receptor complex for the Wnt/PCP
pathway (Wnt-Fzd/Ror2) regardless of the class of Wnt protein.
The results now available indicate that Cthrc1 is a Wnt signaling
component that selectively activates the PCP pathway, and that
its underlying mechanism is enhancement of the Wnt-receptor
interaction by forming a stabilized Cthrc1-Wnt-Fzd/Ror2
complex.
RESULTS
Expression of Cthrc1 in Tissues in Which the PCP Signal
Is Active
To identify the novel genes expressed in the node and the noto-
chord, we generated a single-cell cDNA library of the node/
notochord cell of embryonic day (E) 8.5mouse embryos and per-
formed in situ hybridization screening. This screening identified
Cthrc1 as a gene specifically expressed in the node and the no-
tochord. No signal was observed at E6.5 (Figure 1A). Concomi-
tant with node formation, Cthrc1 expression was initiated in
the node at E7.5 and was extended anteriorly to the notochord
(Figures 1B and 1C). At the later stages, Cthrc1 was also ex-
pressed in other tissues, as reported previously (Durmus et al.,
2006). At E9.5, Cthrc1 was detected in the ventral midline of
the midbrain, dorsal hindbrain, and otic vesicle, as well as the
posterior notochord (Figure 1D). At E18.5, Cthrc1 was also ex-
pressed in the sensory hair cells of the inner ear, including the
crista, utricle, and cochlea (organ of Corti) (Figures 1E–1H). Be-
cause of the similarities between the expression patterns of
Cthrc1 and the adjacent gene, Fzd6, which is involved in PCP
signaling (Wang et al., 2006b), we hypothesized that Cthrc1 is
involved in PCP signaling.
Exencephaly and Misorientation of Cochlear Sensory
Hair Cells in Cthrc1LacZ/LacZ;Vangl2Lp/+ Mice
To reveal the in vivo function ofCthrc1, we generatedCthrc1mu-
tant mice by replacing the first exon with a LacZ gene by using
homologous recombination in embryonic stem (ES) cells
24 Developmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc.(Figure 1I).Cthrc1LacZ/+mice were apparently normal, and the in-
tercross of Cthrc1LacZ/+ mice produced Cthrc1LacZ/LacZ mice,
which did not show any obvious abnormalities and were fertile
(Figure 1J and data not shown). Northern blot analysis of E9.5
embryos confirmed the absence of Cthrc1 transcripts in
Cthrc1LacZ/LacZ embryos (Figure 1K), indicating the null mutation
of Cthrc1. Expression of the adjacent gene, Fzd6, was not af-
fected (Figure 1K). The absence of clear abnormalities in Cthrc1
mutants prompted us to further test our hypothesis by introduc-
ing a heterozygous mutation of the PCP gene Vangl2. Vangl2 is
Figure 1. Expression of Cthrc1 and Production of Cthrc1 Mutant
Mice
(A–D) Whole-mount in situ hybridization showing expression of Cthrc1 in em-
bryos from E6.5 to E9.5.
(E–H) b-Galactosidase activity staining of Cthrc1LacZ/+ embryos showing the
expression of Cthrc1 in the E18.5 inner ear. Cthrc1 is expressed in the (H)
organ of Corti, (E) cochlea, (F) crista, and (G) utricle.
(I) Targeting strategy of theCthrc1 locus. A cassette consisting of LacZ-pA and
PGK-neo-pA (neo) was introduced upstream of the translation initiation codon
together with deletion of coding sequences encoded by exon 1.
(J) External morphology of E15.5 Cthrc1LacZ/+ and Cthrc1LacZ/LacZ embryos.
(K) Northern blot hybridization of E9.5 RNA. Ten micrograms of total RNA was
used for each sample. ps, primitive streak; n, node; nc, notochord; vmb, ven-
tral midbrain; dhb, dorsal hindbrain; ov, otic vesicle.
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and encodes a four-transmembrane protein with a PDZ-do-
main-binding motif (Kibar et al., 2001; Murdoch et al., 2001).
Vangl2Lp/Lp homozygous mutants display typical PCP pheno-
types, including a shortened body axis, an open neural tube,
and misorientation of sensory hair cells of the cochlea, whereas
Vangl2Lp/+ heterozygous mutant mice show a weak PCP-related
phenotype, that is, a looped tail (Greene et al., 1998; Montcou-
quiol et al., 2003). Because mice with a heterozygous mutation
of Vangl2 display a weak PCP-related phenotype, additional in-
troduction of a PCP mutation would exacerbate the mutant phe-
notype. TheCthrc1LacZ/+;Vangl2Lp/+ embryoswere indistinguish-
able from those of Vangl2Lp/+ mice (Figure 2B). By E13.5,
Cthrc1LacZ/LacZ;Vangl2Lp/+ embryos displayed a neural tube clo-
sure defect in the midbrain region reminiscent of the PCP muta-
tion (Figure 2C; Figure S1B available online). Although this defect
was constantly observed in a mixed 129 SvEv/C57B6 back-
ground (n = 2/2 at E13.5, n = 2/2 at E18.5), it was not observed
when mutants were further crossed with outbred (CD-1) mice
(n = 6/6).
To confirm the genetic interactions of Cthrc1 and Vangl2, we
examined another characteristic feature of the PCP mutants—
misorientation of the sensory hair cells in the cochlea. The nor-
mal cochlea has four rows of sensory hair cells—one row of inner
hair cells (IHCs) and three of outer hair cells (OHCs). Each cell
contains an asymmetrically located kinocilium at the outer side
accompanied by a bundle of stereocilia. At E18.5, Cthrc1LacZ/+;
Vangl2Lp/+ embryos showed a normal arrangement of four
rows of hair cells and a uniform hair bundle orientation (Figures
2D–2G). InCthrc1LacZ/LacZ;Vangl2Lp/+ embryos, however, the ori-
entation of the hair bundles was disrupted significantly (Figures
2I–2K). Scanning electron microscopy confirmed the normal or-
ganization of ciliary bundles in the mutants, indicating that the
defect was restricted to cell polarity (Figure 2I). Among the four
rows of auditory hair cells, the IHCs were the most severely af-
fected (Figure 2K). Severe defects were also present in the out-
ermost row of OHCs (OHC3), and modest effects were observed
in the inner rows (OHC1 and OHC2) (Figure 2K). This defect was
not affected by the genetic background of the mutants (n = 8/8).
In addition to the defects in the orientation of individual hair cells,
we observed that some hair cells deviated from the rows, and, in
an extreme case, additional sensory hair cells outside of the four
rows were observed (Figure 2H, arrowheads). These results
demonstrate the genetic interaction of Cthrc1 with Vangl2 for
PCP signaling and suggest that Cthrc1 is involved in the regula-
tion of PCP signaling.
Interaction of Cthrc1 with Extracellular Components
of Wnt/PCP Signaling
Involvement of Cthrc1 in PCP signaling led us to investigate how
Cthrc1 controls PCP signaling. Because Cthrc1 is a secreted
protein and because vertebrate PCP signaling is regulated by
Wnt proteins, we examined the interaction of Cthrc1 with various
extracellular components of Wnt signaling. For this purpose, we
developed an interaction assay that immunoprecipitates the pro-
teins from the lysates of cocultured HEK293T cells that were in-
dividually transfected with expression plasmids for Cthrc1 or
various Wnt components (coculture IP). We used this method
because the conditioned medium of Cthrc1-expressing cellshad no activity (data not shown). We first verified the specificity
of the protein interactions detected with this assay by using es-
tablished interactions. Previous studies suggest the selective in-
teraction of Wnt3a andWnt5a with coreceptors: Wnt5a interacts
with Ror2, but not with LRP5/6, and Wnt3a interacts with LRP5/
6, but not with Ror2 (Liu et al., 2005; Mikels and Nusse, 2006;
Oishi et al., 2003). In coculture IP, Wnt3a- or Wnt5a-expressing
cells and Ror2- or LRP6-expressing cells were mixed and cocul-
tured for 24 hr, and then Ror2 or LRP6 receptors were immuno-
precipitated from the cell lysates (Figure 3A). Consistent with
previous observations, Wnt3a was coprecipitated with LRP6,
but not with Ror2, whereas Wnt5a was coprecipitated with
Ror2, but not with LRP6 (Figure 3B, lanes 7, 8, 11, and 12).
Both Wnt proteins failed to coprecipitate with EGFR or LDLR,
negative controls for Ror2 or LRP6, respectively (Figure 3B,
lanes 9, 10, 13, and 14). Therefore, coculture immunoprecipita-
tion (IP) is a simple and reliable method by which to detect spe-
cific protein-protein interactions in the extracellular space.
Using coculture IP, we first examined the interaction of Cthrc1
with Fzd proteins. Cthrc1 was coprecipitated with Fzd3, Fzd5,
and Fzd6, indicating interaction of Cthrc1 with multiple Fzd pro-
teins (Figure 3C, lanes 6–8). No binding was observed between
Cthrc1 and an Fzd-related protein, Smo, or a C-terminally trun-
cated Cthrc1 (Cthrc1-DC) and Fzd6 (Figure 3C, lanes 9 and
10). We next examined the interaction of Cthrc1 with corecep-
tors Ror2 and LRP6. Cthrc1 was coprecipitated with Ror2
(Figure 3D, lane 8). The lack of interactions between Cthrc1
and EGFR and between Cthrc1-DC and Ror2 demonstrates
the specificity of the Cthrc1-Ror2 interaction (Figure 3D, lanes
10 and 14). Cthrc1 also interacted with Ror2-DCRD, which lacks
a cysteine-rich Wnt-interacting domain, indicating that Cthrc1
and Wnt interact with distinct domains of Ror2 (Figure 3D, lane
9). Cthrc1 was not coprecipitated with LRP6 or its negative con-
trol, LDLR (Figure 3D, lanes 11 and 12).
We next applied coculture IP to interactions between Cthrc1
and Wnt proteins. Although both Cthrc1 and Wnt proteins were
supposed to be secreted, immunoprecipitation of Cthrc1 from
the cell lysates coprecipitated both canonical Wnt (Wnt3a) and
noncanonical Wnt proteins (Wnt5a and Wnt11) (Figure 3E, lanes
7, 10, and 13). Because Wnt proteins were not coprecipitated
with Cthrc1-DC (Figure 3E, lanes 8, 11, and 14), the observed
Cthrc1-Wnt interactions are specific. Finally, we also examined
interaction of Cthrc1 with a transmembrane PCP signaling com-
ponent, Vangl2. Although Cthrc1 and Vangl2 interacted geneti-
cally, these proteins did not interact physically (Figure 3D,
lane 13). In summary, Cthrc1 interacts with multiple extracellular
components of Wnt signaling, which include both canonical and
noncanonical Wnt proteins, Fzd proteins, and the Wnt/PCP cor-
eceptor Ror2, but not with the canonical Wnt coreceptor LRP6 or
the PCP component Vangl2. These results suggest that Cthrc1
regulates PCP signaling by modulating Wnt signaling in the
extracellular space.
Activation of the Wnt/PCP Pathway by Cthrc1
In vertebrates, the Wnt/PCP signal is transduced to two parallel
signaling cascades, a process that starts with the activation of
the small GTPases Rac1 and RhoA, downstream of dishevelled
(Dvl) (Habas et al., 2003). To test whether Cthrc1 actually modu-
lates the PCP pathway, we examined the effects of Cthrc1 on the
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successfully used for the analysis of Wnt/PCP signaling in mam-
mals (Habas et al., 2001, 2003). This cell line expresses Wnts,
Ror2, LRP5/6, and Cthrc1 (Figure S2). To detect the activation
Figure 2. Genetic Interaction between
Cthrc1 and Vangl2
(A–C) Defects in anterior neural tube closure. At
E13.5, (A) Cthrc1LacZ/LacZ embryos were normal,
and (B) Cthrc1LacZ/+;Vangl2Lp/+ embryos showed
only a curly tail phenotype, similar to the
Vangl2Lp/+ embryos. (C)Cthrc1LacZ/LacZ;Vangl2Lp/+
embryos displayed neural tube closure defects in
the midbrain region.
(D–K) Defects in the orientation of ciliary bundles
of sensory hair cells in the organ of Corti. (D and H)
Falloidin staining and (E and I) scanning electron
microscopy of the basal turn (25% from the basal
end) of the organ of Corti. (F) and (J) are schematic
representations of (E) and (I), respectively. (G) and
(K) show the distribution of ciliary bundle orienta-
tion. A total of 54 cells were counted from 2 em-
bryos for each genotype.
of Rac1 and RhoA, we used an estab-
lished biochemical assay that employs
a fusion protein of glutathione S-transfer-
ase and the p21-binding domain of hu-
man PAK-1 (GST-PBD) and GST-RBD
(Rho-binding domain of mouse rhotekin
fused with GST) that recognizes GTP-
bound forms (i.e., active forms) of Rac
and Rho, respectively. Transfection of
the expression plasmids for Wnt3a,
Wnt5a, or Dvl2 activated endogenous
Rac1 (Figure 4A, lanes 3, 5, and 7), and
a similar activation was also observed
by transfection of the Cthrc1 expression
plasmid (Figure 4A, lane 2). Coexpression
of Cthrc1 with Wnt3a, Wnt5a, or Dvl2 fur-
ther enhanced the activation of Rac1
(Figure 4A, lanes 4, 6, and 8). Similarly,
Cthrc1 also activated RhoA (Figure 4B,
lane 2) and enhanced activation of RhoA
by Wnt3a, Wnt5a, or Dvl2 (Figure 4B,
lanes 3–8). These results suggest that
Cthrc1 activates both cascades of the
Wnt/PCP pathway, and this effect is syn-
ergistic with pathway activation by other
signaling components.
Non-Cell-Autonomous Suppression
of Canonical Wnt Signaling by
Cthrc1
Wenext investigated whether Cthrc1 also
modulates canonical Wnt signaling. To
monitor the activation of the canonical
Wnt pathway, we used the Wnt reporter
TOPFLASH, which expresses the lucifer-
ase gene under the control of TCF-bind-
ing sites. Although expression of Cthrc1 by itself had no effect
on the expression of the reporter, when the reporter was acti-
vated by cotransfection ofWnt3a and LRP6 plasmids, Cthrc1 re-
pressed this activation in a dose-dependent manner (Figure 4C).
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lated by an intracellular signaling component, Dvl2, but not by
b-catenin, a component further downstream (Figure 4C).
Intracellular inhibition of the canonical pathway raised the pos-
sibility that overexpressed Cthrc1 acted in the intracellular
space, which could be a nonphysiological function. To exclude
this possibility, the non-cell-autonomous activity of canonical
pathway suppression by Cthrc1 was examined by conducting
coculture experiments. We first prepared effector cells trans-
fected with expression plasmids forWnt3a, Cthrc1, or an empty
plasmid and reporter cells transfected with the TOPFLASH re-
porter. Then, the effector and reporter cells were cocultured for
Figure 3. Interaction of Cthrc1 and Wnt Signaling Components
(A) Scheme of the coculture IP procedure.
(B) Coculture IP detected the specific interaction between Wnt3a/5a and coreceptor Ror2 or LRP6.
(C) Interaction of Cthrc1 with Fzd receptors.
(D) Interaction of Cthrc1 with coreceptors.
(E) Interaction of Cthrc1 with Wnt proteins.
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Wnt3a cells efficiently activated TOPFLASH, and this activation
was clearly suppressed by the presence of Cthrc1 cells
(Figure 4E). Furthermore, activation of TOPFLASH by Dvl2 in
the reporter cells was also suppressed by the presence of Cthrc1
cells (Figure 4E). Suppression was not observed when the re-
porter was activated by b-catenin. These results suggest that
Cthrc1 acts in a non-cell-autonomous manner and suppresses
the canonical pathway. Furthermore, extracellular Cthrc1 also
suppresses the canonical pathway activated by Dvl, although
the underlying mechanism is currently unknown (see the Discus-
sion).
Identification of the Functional Domain of Cthrc1
Because Cthrc1 contains characteristic GXY repeats and an
evolutionally conserved C-terminal region, we studied domains
responsible for the activities of Cthrc1 by using the deletion con-
structs (Figure 5A). Cthrc1 and the GXY-repeat deletion mutant
(DGXY) bound to Wnt3a, Wnt5a, and Wnt11, unlike the C-termi-
nal deletion mutant (DC) (Figure 3E, lanes 7–15). Activation of the
Wnt/PCP pathway revealed by activation of Rac1 and RhoA was
also observed with DGXY, but not with DC (Figures 5B and 5C,
lanes 3 and 4). Similar to full-length Cthrc1, we also observed
a synergistic effect of DGXY and Wnt5a on the activation of
Rac1 and RhoA, whereas DC had no effect on activation of
Rac1 and RhoA by Wnt5a (Figures 5B and 5C, lanes 5–8).
Figure 4. Effect of Cthrc1 on Wnt/PCP and Canon-
ical Wnt Signaling
(A and B) Activation of the Wnt/PCP pathway by Cthrc1.
Cthrc1 weakly activated downstream components of the
PCP pathway: (A) Rac1 and (B) RhoA. Cthrc1 also en-
hanced activation of Rac1 and RhoA by Wnt3a, Wnt5a,
or Dvl2.
(C) Suppression of the canonical Wnt pathway by Cthrc1.
The graphs show the average of two samples with stan-
dard errors.
(D) Scheme of the coculture experiment.
(E) Non-cell-autonomous effect of Cthrc1. Cthrc1 sup-
pressed activation of the canonical pathway in a non-
cell-autonomous manner. The graphs show the average
of two samples with standard errors.
DGXY also suppressed Wnt reporter activity
stimulated by Wnt3a and LRP6 as effectively
as full-length Cthrc1, unlike DC (Figure 5D).
Therefore, the C-terminal region is responsible
for all of the known activities of Cthrc1, and
the GXY repeat is dispensable.
Cthrc1 is an N-glycosylated protein, and
treatment of Cthrc1 in the conditioned medium
(CM) withN-glycosidase F removedN-glycosyl-
ation and resulted in faster migration in SDS-
polyacrylamide gel electrophoresis (PAGE), as
reported previously (Pyagay et al., 2005;
Figure 5E, lanes 1 and 2). The C-terminal region
of Cthrc1 contains a putative N-glycosylation
site. Sequence alteration of this motif (N188A;
replacement of asparagine at position 188 by al-
anine) resulted in faster electrophoretic mobility, and this mobil-
ity was not altered byN-glycosidase F treatment (Figures 5A and
5E, lanes 5 and 6), indicating the absence of N-glycosylation in
N188A. Because N188A bound to Wnt5a and suppressed
canonical Wnt signaling (Figures 5F and 5G), N-glycosylation
of Cthrc1 is dispensable for the Wnt/PCP regulatory activity of
Cthrc1.
Identification of the Active Form of Cthrc1
Coculture of Cthrc1-expressing cells suppressed canonical Wnt
signaling, unlike its conditioned medium (data not shown). To re-
veal the cause of such differences, we compared Cthrc1 pro-
teins in the cell lysate (Cthrc1-L) and in the conditioned medium
(Cthrc1-CM). Cthrc1-CM showed slower migration than Cthrc1-
L on SDS-PAGE (Figure 5E, lanes 1 and 3), indicating that only
the modified protein is released into the medium. Treatment of
Cthrc1-L with N-glycosidase F resulted in faster mobility identi-
cal to that of N188A (Figure 5E, lanes 3 and 4), suggesting that
Cthrc1-L is N-glycosylated and that Cthrc1-CM has an addi-
tional modification that is notN-glycosylation. Although the iden-
tity of this additional modification of Cthrc1-CM is not known, the
modification appeared to depend on N-glycosylation, because
N118A did not produce modified protein in the conditioned me-
dium (Figure 5E, lane 5). Because N188A was reproducibly de-
tected in conditioned medium, although the amount was much
lower than in Cthrc1-CM (note that ten times more conditioned
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(A) Cthrc1 mutants used in this study.
(B–D) Effects of domain deletions on the activation of PCP pathway components, (B) Rac1 and (C) RhoA, and on the (D) suppression of the canonical pathway.
The graphs show the average of two samples with standard errors.
(E–G) Presence of twomodifications in Cthrc1. N188A (E) lacksN-glycosylation, (F) binds toWnt5a, and (G) suppresses canonical Wnt signaling. The graphs show
the average of two samples with standard errors.
(H) Interaction of Wnt signaling components with Cthrc1-L, but not with Cthrc1-CM.
(I–K) Cthrc1 forms a multimer, as revealed by higher molecular weight on (I) nonreducing SDS-PAGE, (J) immunoprecipitation, and (K) coexpression of full-length
Cthrc1 and DGXY.medium was used for N188A-CM in Figure 5E), N-glycosylation
may contribute to the anchorage of Cthrc1 on the cell surface,
and additional modification specific to Cthrc1-CM may release
it. In a coculture IP, immunoprecipitation of Fzd6, Ror2, or
Wnt5a coprecipitated Cthrc1-L from the lysate, but not Cthrc1-
CM, although Cthrc1-CM was also present during the coculture
period (Figure 5H). These results suggest that Cthrc1-L an-
chored on the cell surface is an active protein, whereas
Cthrc1-CM has no activity because it lacks binding activity to
the Wnt/PCP components.When Cthrc1-L and Cthrc1-CM were electrophoresed by us-
ing a nonreducing SDS-PAGE, both proteins produced multiple
bands (Figure 5I, lanes 1 and 2). In addition to the 75 kDa band,
which was previously characterized as a trimer of Cthrc1 pep-
tides (Pyagay et al., 2005), we observed strong bands at 150
kDa, 250 kDa, and a higher molecular mass. DGXY produced
a major band at 70 kDa. Although the GXY repeat resembles
the multimerization domain of collagens, this size of DGXY is
much larger than the size of the monomer and is close to the
size of theCthrc1 trimer. Therefore,DGXYmay also forma trimer.
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tagged and myc-tagged DGXY were coexpressed, immunopre-
cipitation of HA-taggedDGXY coprecipitatedmyc-taggedDGXY
(Figure 5J, lane 8). Furthermore, coexpression of DGXY and full-
length Cthrc1 produced multiple bands around 70–75 kDa
(Figure 5K, lane 3). A similar intermolecular interaction was also
observed with proteins containing the C-terminal region, but
not with DC (Figure 5J, lanes 7–11, and Figure 5K, lane 4). Be-
cause DGXY did not produce multiple bands at a higher molec-
ular mass (Figure 5I, lanes 3 and 4), the GXY repeat is likely to be
involved in the generation of a higher-ordermultimer, i.e., amulti-
mer of the Cthrc1 trimer. Taking these results with those of the
functional analyses described above, the normal active form of
Cthrc1 should be an N-glycosylated trimer anchored on the
cell surface.
Enhancement of the Ligand-Receptor Interaction for the
Wnt/PCP Pathway by Cthrc1
The selective activation of the PCP pathway by Cthrc1 led us to
examine its underlying mechanisms. Because Cthrc1 interacted
with Wnt and receptors, Cthrc1 may modulate the ligand-recep-
tor interaction. We tested this hypothesis in coculture IP by pre-
cipitating the receptors from lysates of cocultured cells, which
individually express Wnt, Cthrc1, or receptors, followed by de-
termination of the amount of coprecipitated Wnt proteins by
western blot. We first examined whether interaction of Wnt and
Fzd proteins is influenced by Cthrc1. We used Wnt3a and
Wnt5a as representative canonical and noncanonical Wnt pro-
teins, respectively. As shown in Figure 6A, Cthrc1 and Wnt3a
were coprecipitated with Fzd5, and Cthrc1 enhanced binding
of Wnt3a and Fzd5, as revealed by the stronger band of precip-
itatedWnt3a (lanes 6 and 7). Relative amounts of the precipitated
Wnt proteins were quantified and are represented as shown in
Figure 6A0. Similar enhancement of the Wnt-Fzd interaction by
Cthrc1 was also observed for all of the combinations of Wnt3a/
Wnt5a and Fzd5/Fzd6 (Figures 6A and 6A0, lanes 6–13). The ab-
sence of the enhancement of the Wnt-Fz interaction by Cthrc1-
DC (Figures S3A and S3A0) and the absence of an interaction
between Cthrc1-Wnt and Smo (Figure 6A, lanes 14 and 15) con-
firmed the specificity of this effect. Therefore, Cthrc1 forms a ter-
nary complex of Cthrc1-Wnt-Fzd and enhances the interaction
between Wnt proteins and Fzd proteins. There is no clear prefer-
ence in this enhancement based on the classes of Wnt proteins.
We next examined the effect of Cthrc1 on the interaction
between Wnt proteins and the pathway-specific coreceptors
Ror2 (PCP pathway) and LRP6 (canonical pathway). As shown
in Figures 6B and 6B0,Wnt3awas not significantly coprecipitated
with Ror2; however, in the presence of Cthrc1,Wnt3awas clearly
coprecipitatedwith Ror2 (lanes 6 and 7). Cthrc1 did not affect the
interaction ofWnt3a and LRP6 (lanes 8 and 9).Wnt5awas copre-
cipitated with Ror2, and, in the presence of Cthrc1, this interac-
tion was enhanced, as revealed by stronger bands (lanes 10 and
11). Wnt5awas not coprecipitated with LRP6, and Cthrc1 did not
affect the binding ofWnt5a and LRP6 (lanes 12 and 13). Confirm-
ing the specificity of the observed interactions, Cthrc1-DC had
no effect on the interaction of Wnt3a/5a and Ror2 (Figures S3B
and S3B0), and no binding of Cthrc1-Wnt and EGFR was ob-
served (Figure 6B, lanes 14 and 15). Therefore, regardless of
the Wnt class, Cthrc1 selectively enhanced the interaction be-
30 Developmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc.tween Wnt and Ror2 by forming the ternary complex Cthrc1-
Wnt-Ror2.
Although Cthrc1 generally enhanced the Wnt-Fzd interaction,
it selectively enhanced theWnt-coreceptor interaction. Because
both Fzd and coreceptors may be present in the normal situa-
tion, we next examined whether selective enhancement of the
Wnt-(co)receptor interaction was also observed under such con-
ditions. In these experiments, Fzd and coreceptor were ex-
pressed in the same cells. As shown in Figures 6C and 6C0,
Cthrc1, Wnt3a, and Ror2 or LRP6 were coprecipitated with
Fzd6, and Cthrc1 enhanced the Wnt3a-Fzd6 interaction in the
presence of Ror2 (lanes 7 and 8), but not in the presence of
LRP6 (lanes 9 and 10). Similarly, Ror2-specific enhancement of
the Wnt5a-Fzd6 interaction by Cthrc1 was also observed (lanes
11–14). No enhancement was observed with Cthrc1-DC (Figures
S3C and S3C0). Immunoprecipitation of Ror2 or LRP6 from the
lysates further confirmed the selective enhancement of the
Wnt3a/5a-Fzd6-Ror2 interaction by Cthrc1, and no enhance-
ment of the Wnt3a/5a-Fzd6-LRP6 interaction (Figures 6D and
6D0). Again, no enhancement was observedwith Cthrc1-DC (Fig-
ures S3D and S3D0). Essentially, the same results were obtained
with Fzd5, indicating that the effect of Cthrc1 is not specific to
Fzd6 (data not shown). Therefore, in the presence of both Fzd
and coreceptors, general enhancement of binding of Wnt and
Fzd by Cthrc1 was not observed. Instead, Cthrc1 selectively
enhanced the interaction of Wnt with receptors for the PCP
pathway, Fzd and Ror2, by forming the complex of Cthrc1-
Wnt-Fzd, Cthrc1-Wnt-Ror2, or Cthrc1-Wnt-Fzd-Ror2. These
three complexes are hereafter collectively referred to as
Cthrc1-Wnt-Fzd/Ror2. Such pathway-specific enhancement of
the ligand-receptor interaction is likely to be a molecular basis
for the selective activation of the Wnt/PCP pathway by Cthrc1.
Misorientation of the Cochlear Sensory Hair Cells in
Ror2/ Mice
The interaction analyses suggest that Ror2 plays a key role in the
selective activation of Wnt/PCP signaling by Cthrc1. Although
Ror2 has been characterized as a Wnt receptor activating Wnt/
PCP signaling in cell culture and frog embryos (Hikasa et al.,
2002; Oishi et al., 2003), the relationship between abnormalities
reported with Ror2/ mutant mice (e.g., short limbs and tails)
(DeChiara et al., 2000; Takeuchi et al., 2000), and PCP signaling
is currently unclear. If Cthrc1 functions by forming the Cthrc1-
Wnt-Fzd/Ror2 complex, Ror2/ mutants should also exhibit
PCP-related inner ear defects similar to those of Cthrc1LacZ/LacZ;
Vangl2Lp/+ embryos. Whole-mount in situ hybridization revealed
widespread expression of Ror2 in E18.5 cochlea, but the
strong signal was restricted to the sensory hair cells of the organ
of Corti (Figure 7A, left), which also express Cthrc1 (Figure 1H).
No signal was observed with a sense probe (Figure 7A, right).
At E18.5, all of the Ror2/ embryos showed disruption in orga-
nization of the organ of Corti (n = 5/5). Two of them showed
strong randomization of orientation of auditory hair cells as
well as disturbance of the alignment of OHCs into three rows
with a local increase or decrease in the number of rows of
OHCs (Figures 7D, 7E, and 7I, and data not shown). In the other
three, abnormalities in the alignment of OHCs into three rows
were evident, and the disruption of cell orientation was weak
(Figures 7F, 7G, and 7J). Although the latter phenotype has not
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Activation of Wnt/PCP Pathways by Cthrc1Figure 6. Effects of Cthrc1 on the Wnt-Receptor Interaction
(A–D) (A) Effects of Cthrc1 on the Wnt-Fzd interaction. (B) Effects of Cthrc1 on the Wnt-coreceptor interaction. (C and D) Effects of Cthrc1 on the Wnt-Fzd-
coreceptor interaction. (A and C) Fzd or (B and D) coreceptors were immunoprecipitated from the cocultured lysates.
(A0–D0) Graphs representing the relative amounts of precipitated Wnt proteins in the experiments shown in (A)–(D), respectively. Lane numbers correspond to
those in (A)–(D). Values are normalized to intensities without Cthrc1 as 1.Developmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc. 31
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Activation of Wnt/PCP Pathways by Cthrc1Figure 7. Involvement of Ror2 in PCP Signaling in Inner Ear Development
(A) Expression of Ror2 mRNA in the inner ear.
(B–J) Defects of alignment and orientation of sensory hair cells. (B, D, and F) Scanning electronmicroscopy of the basal turn of the organ of Corti of (B) control and
(D and F) Ror2 homozygousmutant embryos. (C), (E), and (G) are schematic representations of (B), (D), and (F), respectively. (H)–(J) show the distribution of ciliary
bundle orientation. Data in (H) were from two control embryos, and data in (I) and (J) were from the embryos shown in (D) and (J), respectively.
(K) Model of selective activation of the Wnt/PCP pathway by Cthrc1.32 Developmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc.
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a representative abnormality observed with PCP mutants.
Therefore, these results suggest that Ror2 regulates PCP signal-
ing in inner ear development and supports the hypothesis that
Cthrc1 forms a Cthrc1-Wnt-Fzd/Ror2 complex to activate PCP
signaling in this tissue.
DISCUSSION
Previous studies revealed several mechanisms for pathway se-
lection by Wnt proteins, which include intrinsic differences of
Wnt and Fzd proteins and the availability of coreceptor proteins
Ror2 and LRP5/6. We identified Cthrc1 as an extracellular com-
ponent of the Wnt pathway that contributes to selective activa-
tion of the PCP pathway. This finding suggests the existence
of a regulatory mechanism for pathway selection by Wnt pro-
teins, which we would like to summarize in the following model
(Figure 7K). There are some intrinsic preferences for interactions
amongWnt, Fzd, and coreceptor proteins (Liu et al., 2005;Mikels
and Nusse, 2006; Takada et al., 2005). However, in the condi-
tions in which appropriate receptors are available, these Wnt
proteins may form both Wnt-Fzd-LRP5/6 and Wnt-Fzd/Ror2
complexes and activate the canonical Wnt and Wnt/PCP path-
ways. The interaction ofWnt proteins with Fzd/Ror2 is selectively
enhanced in the presence of Cthrc1 by forming the Cthrc1-Wnt-
Fzd/Ror2 complex. Although Wnt-Fzd and Wnt-Ror2 have been
implicated in noncanonical Wnt signaling, whether Fzd and Ror2
act within a single receptor complex, or whether they act in two
parallel pathways, is currently not known. Our results did not
resolve this issue, and, therefore, the Cthrc1-Wnt-Fzd/Ror2
complex could be Cthrc1-Wnt-Fzd, Cthrc1-Wnt-Ror2, or
Cthrc1-Wnt-Fzd-Ror2. However, we prefer the model of Cthrc1-
Wnt-Fzd-Ror2 complex formation, because it is known that Ror2
interacts with several Fzd proteins (Oishi et al., 2003), and be-
cause the cell migratory activity ofWnt5a/Ror2 signaling requires
Dvl, a downstream effector of Fzd signaling (Nishita et al., 2006).
The effect of Cthrc1 is not restricted to the enhancement of pre-
existing interactions, such as that of Wnt5a with Ror2, and it also
establishes new interactions, such as that of Wnt3a with Ror2.
The normal active form of Cthrc1 is an N-glycosylated trimer an-
chored on the cell surface. Because Cthrc1 interacts with Wnt
proteins, Fzd proteins, and Ror2, Cthrc1 may bridge these pro-
teins through trimer formation. Cthrc1 does not bind to LRP5/
6, and the interaction of Wnt with Fzd-LRP5/6 is not affected
by Cthrc1. The selective enhancement of Wnt-receptor binding
results in the selective activation of the Wnt/PCP pathway and
suppression of the canonical pathway. Suppression of the ca-
nonical pathway should be a secondary effect as a result of
strong activation of the PCP pathway, because interaction of
Wnt and Fzd-LRP6 was not affected by Cthrc1, and because ac-
tivation of PCP signaling with intracellular components sup-
presses the canonical Wnt pathway (Park and Moon, 2002; Vee-
man et al., 2003b). Expression of multipleWnt genes in HEK293T
cells obscured whether Cthrc1 by itself is sufficient for activation
of the PCP pathway or whether Wnt proteins are required.
Although we could not rule out the former possibility, the forma-
tion of a Cthrc1-Wnt-Fzd/Ror2 complex supports the latter
mechanism.In vivo, the model of PCP activation by the Cthrc1-Wnt-Fzd/
Ror2 complex is best supported by inner ear development.
The cochlea undergoes a morphogenetic movement known as
‘‘convergent extension’’ to elongate and properly align the sen-
sory hair cells of the organ of Corti (Qian et al., 2007). Such mor-
phogenesis is disrupted in mouse mutants of PCP signaling
components (Vangl2, Celsr1) (Montcouquiol et al., 2003; Wang
et al., 2005), and similar defects are also observed with the
mouse mutants Cthrc1LacZ/LacZ;Vangl2Lp/+, Wnt5a/, Fzd3/;
Fzd6/, and Ror2/, which was consistent with our study
(Qian et al., 2007; Wang et al., 2006b). Therefore, it is conceiv-
able that the Cthrc1-Wnt5a-Fzd3/Fzd6/Ror2 complex activates
PCP signaling in this tissue. Although Wnt7a is also expressed
in the cochlea (Dabdoub et al., 2003), no activation of canonical
Wnt signaling is observed (Qian et al., 2007). Therefore, Cthrc1
may also support cochlea development by assuring the selective
activation of the PCP pathway byWnt proteins. Although overex-
pression of Cthrc1 clearly suppresses the canonical Wnt path-
way, to determine whether endogenous levels of Cthrc1 are
sufficient for this activity requires further research. A similar
mechanismmay also take place in the notochord, which strongly
expresses Cthrc1, because the notochord also undergoes con-
vergent extension regulated by PCP signaling (Wang et al.,
2006a; Ybot-Gonzalez et al., 2007), and canonical Wnt signaling
should be suppressed in notochord development.
Cthrc1 promotes cell migration by reducing the deposition of
the collagen matrix (Pyagay et al., 2005). We speculate that
Wnt/PCP pathway activation by Cthrc1 also contributes to the
promotion of cell motility. Because the PCP pathway regulates
actin polymerization through activation of the small GTPases,
JNK, and ROCK, activation of the PCP pathway should alter
cellular morphology and increase cellular motility. During cancer
development (Katoh and Katoh, 2007) andwound healing (Labus
et al., 1998), activation of canonical Wnt signaling by transcrip-
tional activation of canonical Wnt proteins and/or epigenetic si-
lencing of secreted Wnt antagonists is observed. Therefore, ad-
ditional expression of Cthrc1 to these cells (Pyagay et al., 2005;
Tang et al., 2006) likely results in the activation of the PCP path-
way and promotion of cellular motility. Consistent with this no-
tion, Wnt/PCP signaling-related genes are overexpressed in
somemalignant (i.e., invasive and/or metastatic) human cancers
(Katoh, 2005). Therefore, it is conceivable that Cthrc1 is a multi-
functional protein and promotes cell migration through activation
of Wnt/PCP signaling and reduction in collagen matrix deposi-
tion.Multifunctionality of Cthrc1 is also reported for TGF-b signal-
ing. Cthrc1 in the conditioned medium, which has a specific
modification and lacks Wnt modulating activity (this study),
inhibits TGF-b signaling (LeClair et al., 2007), suggesting that
modifications control the activity and localization of Cthrc1.
In conclusion, we identified a Wnt cofactor protein, Cthrc1,
that promotes selective activation of the PCP pathway by en-
hancing the Wnt-receptor interaction. Identification of Cthrc1
suggests a mechanism for pathway selection by the Wnt pro-
teins. This mechanism may be used widely in the regulation of
morphogenesis during development and cell motility in wound
healing and cancer metastasis. In an evolutionary context, it is
of interest to note that Cthrc1 is present only in chordates (Pya-
gay et al., 2005), which use Wnt proteins for PCP signaling
(Jones and Chen, 2007). The absence of apparent abnormalityDevelopmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc. 33
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dundant genes. The absence of Cthrc1-related genes in the
mouse genome suggests that structurally distinct genes com-
pensate for the absence of Cthrc1. Identification of such genes
in the future should facilitate understanding of the mechanism
of pathway selection by Wnt proteins.
EXPERIMENTAL PROCEDURES
Construction of a Single-Cell Notochord Library and In Situ
Hybridization Screening
Transgenic mouse embryos expressing enhanced green fluorescent proteins
(EGFPs) in the node and the notochord were obtained by crossing the two
transgenic lines, CAG-CAT-EGFP (Kawamoto et al., 2000) and Not-Cre, which
express Cre recombinase in the notochord (unpublished data). After the disso-
ciation of E8.25 transgenic embryos by trypsin treatment, EGFP-positive node
or notochord cells were manually picked up with a glass capillary under a fluo-
rescence microscope. cDNAs from single node/notochord cells were synthe-
sized and amplified as described previously (Yabuta et al., 2006). The resulting
cDNA pools were analyzed individually for the appropriate gene expression
profiles by virtual northern blot with Foxa2, brachyury, Shh, Sox17, Mox1,
Twist, and Ncam1 probes. The efficiency of cDNA amplification was assessed
by using a G6PDH probe. A single-cell cDNA pool that showed clear expres-
sion of Foxa2, brachyury, and Shh, but not other genes, was selected for con-
struction of a cDNA library in pBluescript II SK() (Stratagene). A total of 5292
clones were spotted on a nylon membrane in a 384-well format and were hy-
bridized with total E9.5 cDNA probes. Abundantly expressed genes, which
showed clear signals, were removed, and the remaining 2264 clones were se-
quenced and clustered. A total of 524 clones were analyzed for gene expres-
sion pattern bywhole-mount in situ hybridization in 96-well plates as described
previously (Neidhardt et al., 2000). This screening identified several genes
expressed in the node and/or the notochord, including Cthrc1.
Generation of Cthrc1 Mutant Mice
Cthrc1mutantmice (CDB0502K) were generated as follows. A targeting vector
was constructed by inserting a cassette consisting of LacZ-pA and PGK-neo-
pA into the first exon of Cthrc1 to replace the coding sequence with LacZ
(Figure 1I). EB3EScells (Niwa et al., 2002)were electroporatedwith a linearized
targeting vector and selected by G418, blasticidin S, and diphtheria toxin A
fragment. ES cells carrying a recombinant allele were injected into eight-cell
embryos of C57BL/6 mice to generate chimeric mice. Chimeric founders
from two independent ES cell lines were crossed with C57BL/6 mice, and
the resulting mutant mouse line was maintained on a C57BL/6 or CD1 back-
ground. Mice were housed in environmentally controlled rooms of the Labora-
tory Animal Housing Facility of the RIKEN Center for Developmental Biology,
under the institutional guidelines for animal and recombinant DNA experi-
ments. Other mouse strains and procedures for genotype determination are
described in the Supplemental Data.
Analysis of the Organ of Corti
Temporal bones were dissected frommutant embryos at E18.5. The surround-
ing cartilage was removed to expose the cochlea, and the anlage of Reissner’s
membrane was dissected to expose the sensory epithelium. Dissected tissues
were fixed in 4% paraformaldehyde at room temperature for 1 hr. To visualize
the orientations of the stereociliary bundle, fixed tissues were stained with
Alexa 568 phalloidin (Molecular Probes), as previously described (Wang
et al., 2006b). Confocal images were obtained with an LSM510 META laser
scanning microscope (Zeiss). For scanning electron microscopy, tissues
were fixed with 2% fresh formaldehyde and 2.5% glutaraldehyde in 0.1 M so-
dium cacodylate buffer (pH 7.4) for 2 hr, followed by postfixation with 1%OsO4
in the same buffer for 2 hr on ice. Samples were then dehydrated in a graded
ethanol series, transferred into isoamyl acetate, and dried in a critical point
drier (JCPD-5; JEOL) after substitution with liquid CO2. Dried samples were
coated with platinum by using a sputter coater (JFC-1600; JEOL) and were
examined under a scanning electron microscope (JSM-5600LV; JEOL) at an
accelerating voltage of 10 kV.34 Developmental Cell 15, 23–36, July 2008 ª2008 Elsevier Inc.Northern Blot Analysis
Total RNA was isolated by using Trizol reagent (Invitrogen) from E9.5 mutant
embryos. Northern blot analysis was performed by following standard proce-
dures with full-length Cthrc1 and Fzd6 cDNAs as probes. Radioactive signals
were detected with a BAS-2500 Bio-Image Analyzer (FujiFilm, Tokyo Japan).
Rho and Rac Activation Assay
HEK293T cells (43 105) were seeded in each well of six-well plates. After over-
night culture, 0.9 mg expression plasmids was transfected by using FuGENE
HD (Roche). For transfection, 500 ng Cthrc1/Cthrc1-DC/Cthrc1-DGXY and
100 ng Wnt3a/Wnt5a/Dvl2 of pCAGGS-based expression plasmids were
used. The amount of transfected DNAwas adjusted to 0.9 mg by adding appro-
priate amounts of the empty vector (pCAGGS). Twenty-four hours after trans-
fection, the cells were lysed, and activation of RhoA and Rac1 was examined
with a RhoA and Rac1 activation assay kit (Upstate, VA USA) according to the
manufacturer’s instructions. The plasmids are described in the Supplemental
Data.
Coculture Immunoprecipitation Assay
To prepare protein-expressing cells, HEK293T cells (2 3 106) were seeded in
10 cm dishes for 24 hr, after which the cells were transfected with 4.5 mg
pCAGGS-based expression plasmids by using FuGENE HD (Roche). Five
hours after transfection, cells were trypsinized andmixed in the ratio described
below, and 13 106 cells were replated in six-well plates for coculture. Recep-
tor cells and ligand cells were mixed in a ratio of 1:4 to detect the interaction of
one receptor and one ligand (Figures 3 and 5). The HA-tagged receptor was
immunoprecipitated in all experiments. Similarly, to study the interaction of
one receptor and two ligands, a 1:2:2 ratio of receptor:ligand 1:ligand 2 was
used (Figures 6A and 6B). To detect the interaction of two receptors and
two ligands (Figures 6C and 6D), 2.25 mg of each receptor-expressing plasmid
was cotransfected to prepare receptor-expressing cells. The ligand-receptor
cell ratio of receptor (1 + 2):ligand 1:ligand 2 was 1:2:2. After 24 hr of coculture,
cell lysates were prepared by lysing the cells with 500 ml lysis buffer (50 mM
Tris-HCl [pH 8.0], 150mMNaCl, 1%NP-40, complete protease inhibitor cock-
tail [Roche]) and removing the insoluble materials by centrifugation at 12,0003
g for 10min at 4C. A total of 15 ml of the lysates was used as whole-cell lysates
by adding 15 ml 23 SDS sample buffer. The remaining lysates were subjected
to immunoprecipitation by incubation with 2 mg anti-HA polyclonal antibody
(Y-11; Santa Cruz Biotechnology) at 4C overnight. Then, 20 ml Protein G
Plus-Agarose (Santa Cruz Biotechnology) was added to the lysates, which
were further incubated at 4C for 90 min. Immune complexes were precipi-
tated by centrifugation at 1,0003 g for 2 min, washed four times with 1ml lysis
buffer, and dissolved in 30 ml 23 SDS sample buffer. Immunoprecipitates or
whole-cell lysates were separated by SDS-PAGE and blotted onto nitrocellu-
lose membranes (Whatman). Membranes were probed with anti-HA (F-7)
(Santa Cruz Biotechnology), anti-myc (9E10) (Santa Cruz Biotechnology), or
anti-Flag M2 (Sigma) monoclonal antibodies and were detected by using
CDP-Star (Roche). Chemiluminescent signals were detected and quantified
by using an LAS-3000 mini lumino image analyzer (FujiFilm). The plasmids
are described in the Supplemental Data.
Luciferase Assay
For cotransfection experiments, 1 3 105 HEK293T cells were seeded in 24-
well plates 1 day prior to transfection. The cells were transfected with a 250 ng
DNA mixture by using FuGENE HD (Roche) and were cultured for 24 hr. The
DNA mixture consisted of TOPFLASH reporter (100 ng) (a gift from M. Hibi),
pCS2-bgal reference (50 ng) (a gift from M. Hibi), and 100 ng pCAGGS-based
effector plasmids. The following amounts of effector plasmids were used:
Wnt3a, 0.1 ng; LRP6, 0.1 ng; Cthrc1, 50, 25, and 10 ng; b-catenin, 25 ng;
and Dvl2, 50 ng. The amount of effector DNA was adjusted to 100 ng by addi-
tion of an appropriate amount of an empty vector (pCAGGS). Cell lysates were
prepared, and luciferase and b-galactosidase activities were measured as de-
scribed previously (Sasaki et al., 1999). For coculture experiments, 2 3 106
HEK293T cells were seeded per 10 cm dish on the day before transfection.
A total of 4.5 mg plasmid DNA was transfected by using FuGENE HD (Roche)
to prepare effector and reporter cells. Effector cells were transfected with 4.5
mg pCAGGS-based expression plasmids for Wnt3a, Cthrc1, and an empty
vector (pCAGGS). Reporter cells were transfected with TOPFLASH (500 ng),
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based expression plasmids for Dvl2 (250 ng) and b-catenin (125 ng) were
also included, keeping the total DNA amount to 4.5 mg by reducing the amount
of pCAGGS. After 5 hr of transfection, reporter and effector cells were trypsi-
nized and mixed in the ratio of 1:2:2 (reporter:effector 1:effector 2) and seeded
in 24-well plates. After 24 hr of incubation, luciferase and b-galactosidase ac-
tivities were measured. Luciferase activities were normalized to b-galactosi-
dase activities. The graphs show the average of two samples with standard
errors.
Characterization of Cthrc1
One day before transfection, HEK293T cells (4 3 105) were seeded in six-well
plates with 2 ml medium. Cthrc1 expression plasmids (0.9 mg) were trans-
fected by using FuGENE HD (Roche) and were cultured for 24 hr. The medium
was used as a conditionedmedium, and cell lysate was prepared as in the pro-
cedures for coculture IP. Samples were diluted 10-fold, except for the condi-
tioned medium of the N188A mutant. Conditioned medium (2.5 ml) was treated
with 1 mU N-glycosidase F (Glycopeptidase F, Takara Bio Inc., Shiga, Japan)
by following the manufacturer’s instructions.
Reverse Transcription-PCR
Total RNAs were isolated from HEK293T cells by using Trizol reagent (Invitro-
gen) according to themanufacturer’s instructions. Onemicrogram of total RNA
was used for cDNA synthesis by using Superscript III reverse transcriptase (In-
vitrogen) according to the manufacturer’s instructions. The resulting cDNA
was diluted appropriately for semiquantitative PCR. Primers for Wnts, LRPs,
and HPRT were as described by Etheridge et al. (2004), and that for Ror2
was as described by Oishi et al. (2003). Primers for Cthrc1 were
50-TTTCTGGAACCCATGGAGAG-30 and 50-AGCCAGCACCTCCTTCTACA-30.
The PCR conditions were 95C for 1 min; 25, 30, or 35 cycles of 95C for
30 s; 58C for 30 s; and 72C for 1 min, followed by 72C for 5 min.
SUPPLEMENTAL DATA
Supplemental Data include three figures, Supplemental Experimental Proce-
dures, and Supplemental References and are available at http://www.
developmentalcell.com/cgi/content/full/15/1/23/DC1/.
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